Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience episode artwork

EPISODE · Jun 15, 2026 · 16 MIN

Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

from Neuro-Oncology: The Podcast · host John Fortunato, Sofia Rael, Ugur Sener

Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener    Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled "Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience."

NOW PLAYING

Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience

0:00 16:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 16 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on June 15, 2026.

What is this episode about?

Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener    Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled "Ivosidenib in predominantly recurrent...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!